Next Article in Journal
Applications of Lactic Acid Bacteria and Their Bacteriocins against Food Spoilage Microorganisms and Foodborne Pathogens
Previous Article in Journal
Recent Advances in C-F Bond Cleavage Enabled by Visible Light Photoredox Catalysis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Solubility of Cinnarizine in (Transcutol + Water) Mixtures: Determination, Hansen Solubility Parameters, Correlation, and Thermodynamics

1
Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia
2
Department of Pharmacognosy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia
*
Author to whom correspondence should be addressed.
Submission received: 31 October 2021 / Revised: 15 November 2021 / Accepted: 20 November 2021 / Published: 22 November 2021
(This article belongs to the Section Physical Chemistry)

Abstract

:
Between 293.2 and 313.2 K and at 0.1 MPa, the solubility of the weak base, cinnarizine (CNZ) (3), in various {Transcutol-P (TP) (1) + water (2)} combinations is reported. The Hansen solubility parameters (HSP) of CNZ and various {(TP) (1) + water (2)} mixtures free of CNZ were also predicted using HSPiP software. Five distinct cosolvency-based mathematical models were used to link the experimentally determined solubility data of CNZ. The solubility of CNZ in mole fraction was increased with elevated temperature and TP mass fraction in {(TP) (1) + water (2)} combinations. The maximum solubility of CNZ in mole fraction was achieved in neat TP (5.83 × 10−2 at 313.2 K) followed by the minimum in neat water (3.91 × 10−8 at 293.2 K). The values of mean percent deviation (MPD) were estimated as 2.27%, 5.15%, 27.76%, 1.24% and 1.52% for the “Apelblat, van’t Hoff, Yalkowsky–Roseman, Jouyban–Acree, and Jouyban–Acree–van’t Hoff models”, respectively, indicating good correlations. The HSP value of CNZ was closed with that of neat TP, suggesting the maximum solubilization of CNZ in TP compared with neat water and other aqueous mixtures of TP and water. The outcomes of the apparent thermodynamic analysis revealed that CNZ dissolution was endothermic and entropy-driven in all of the {(TP) (1) + water (2)} systems investigated. For {(TP) (1) + water (2)} mixtures, the enthalpy-driven mechanism was determined to be the driven mechanism for CNZ solvation. TP has great potential for solubilizing the weak base, CNZ, in water, as demonstrated by these results.

1. Introduction

Cinnarizine (CNZ) (Figure 1, IUPAC name: 1-benzhydryl-4-[(E)-3-phenylprop-2-enyl]piperazine, CAS number: 298-57-7, PubChem CID: 1547484, molecular formula: C26H28N2, and molar mass: 368.50 g mol−1) appears as a white crystalline powder [1,2]. It is used as an antihistaminic and blood-flow promoter [2,3]. The biopharmaceutical classification system (BCS) classifies it as a BCS class II drug, meaning it has poor aqueous solubility and high permeability [1,4]. It is a weak base, which is practically insoluble in water with a high partition coefficient value (log P = 5.8) [5]. Hence, the bioavailability and oral absorption of CNZ are limited by its low solubility and poor dissolution rate [1]. CNZ is a non-efficient drug molecule due to its low solubility, stability, and poor bioavailability from a physicochemical viewpoint [1,2,3,4,5]. Various lipid-based drug delivery systems, such as self-nanoemulsifying drug delivery systems (SNEDDS) and solidified SNEDDS, have been developed to modify the physicochemical characteristics of CNZ [2,6,7,8,9,10,11,12,13,14].
Physicochemically, the solubility of active pharmaceutical compounds is an important property for the purification, production, dosage form design, and application of these compounds [1,15,16]. The literature on the solubility data of CNZ in aqueous cosolvent mixtures is limited. It has pH-dependent solubility in aqueous media [2]. Its solubility increases with decreases in pH, and vice versa. The solubility of CNZ has been reported as 0.29 mg mL−1 in an aqueous buffer with pH = 2.0, 0.017 mg mL−1, pH = 5.0, and 0.002 mg mL−1, pH = 6.5 at 310.2 K [2]. The solubility of CNZ has also been reported in water and four organic solvents such as acetonitrile, butyl acetate, 1-butanol, and 2-propanol between 288.15 and 313.15 K [1].
The solubility values and thermodynamic properties of CNZ (3) are not known in various {Transcutol-P (TP) (1) + water (2)} mixtures from 293.2–313.2 K and at 0.1 MPa. Thus, this study evaluated the equilibrium solubility values and thermophysical characteristics of CNZ (3) in various {TP (1) + water (2)} combinations along with pure TP and pure water between 293.2 and 313.2 K and at 0.1 MPa. From a pharmaceutical point of view, TP is a safe and Food and Drug Administration (FDA)-approved solubilizer [2]. It is used as a potential solubilizer/cosolvent in the preparation of various lipid-based drug delivery systems [2,9,17]. Recently, it has also been studied as a potential solubilizer in the solubility enhancement of various poorly soluble drugs, including sunitinib malate, flufenamic acid, sinapic acid, apremilast, ketokonazole, and sulphadiazine [18,19,20,21,22,23]. Due to these reasons, it was selected as a cosolvent in this study.

2. Results and Discussion

2.1. Mole Fraction Solubility Data of CNZ

Between 293.2 and 313.2 K and atmospheric pressure, Table 1 lists the solubility values of CNZ in mole fraction (3) in binary {TP (1) + water (2)} combinations, including neat TP and neat water. The solubility of CNZ in mole fraction (3) in different {TP (1) + water (2)} combinations at various temperatures is unknown. However, the solubility of CNZ in mole fractions in water has been measured at various temperatures [1]. The mole fraction solubility of CNZ in water was reported to be 6.63 × 10−8, 7.71 × 10−8, and 9.35 × 10−8 at 298.3 K, 303.0 K, and 307.8 K, respectively [1]. The mole fraction solubility of CNZ in water was determined to be 5.67 × 10−8, 7.82 × 10−8, and 9.78 × 10−8 at three closed temperatures of 298.2 K, 303.2 K, and 308.2 K, respectively. In neat water, these CNZ mole fraction solubility values were similar to those previously reported in the literature [1].
The mole fraction solubility of CNZ was determined to be the lowest in neat water and the highest in neat TP. The low polarity of TP relative to the high polarity of water may explain the maximal CNZ solubility in neat TP [18,19]. The solubility of CNZ (3) in binary {TP (1) + water (2)} combinations was observed to increase with elevated temperatures and increase in TP mass fraction at constant pressure (0.1 MPa) between 293.2 and 313.2 K. Between 293.2 and 313.2 K, the effect of TP mass fraction on the logarithmic mole fraction solubility of CNZ was also investigated, and the findings are shown in Figure 2. At all five temperatures tested, the logarithmic solubility of CNZ in mole fraction was enhanced consistently with an increase in TP mass fraction in binary {TP (1) + water (2)} combinations. The logarithmic solubility of CNZ in mole fraction was likewise shown to enhance significantly from pure water to pure TP. As a result, TP has the potential to be employed as a solubilizer/cosolvent in the solubilization of CNZ in water.

2.2. Hansen Solubility Parameters (HSPs)

The total HSP (δt) for CNZ was estimated to be 19.40 MPa1/2 using HSPiP software and Equation (1). HSP values for neat TP (δ1) and neat water (δ2) were anticipated to be 21.40 and 47.80 MPa1/2, respectively. Equation (2) was used to calculate the HSP value for various {TP (1) + water (2)} combinations free of CNZ (δmix). The δmix values were estimated to be between 24.04 and 45.16 MPa1/2. Overall, the HSP of neat TP (δ1 = 21.40 MPa1/2) and CNZ (δt = 19.40 MPa1/2) were very close. The solubility of CNZ in neat TP was likewise found to be the highest in the experiments. As a result, these findings were in good accord with the CNZ solubility data obtained from experiments with {TP (1) + water (2)} combinations.

2.3. Cosolvency-Based Mathematical Models for CNZ Solubility Correlation

Five distinct cosolvency-based mathematical models, including the modified “Apelblat, van’t Hoff, Yalkowsky–Roseman, Jouyban–Acree, and Jouyban–Acree–van’t Hoff models” were used to link the measured solubility values of CNZ [18,19,20,24,25,26,27]. Table 2 summarizes the results for the correlation of CNZ in binary {TP (1) + water (2)} combinations with the modified “Apelblat model”. The overall mean percent deviation (MPD) for this model was estimated to be 2.27%. The determination coefficient (R2) for CNZ (3) in all cosolvent combinations with neat solvents was obtained at between 0.9955 and 0.9998. These findings revealed a strong connection between the experimental CNZ (3) solubility data and the modified “Apelblat model” in binary {TP (1) + water (2)} combinations.
Table 3 summarizes the results for the correlation of CNZ in binary {TP (1) + water (2)} combinations with the “van’t Hoff model”. The overall MPD for the “van’t Hoff model” was estimated to be 5.15%. The R2 for CNZ (3) in all cosolvent mixtures with neat solvents was obtained at between 0.9947 and 0.9993. These findings also revealed a strong connection between experimental CNZ (3) solubility data and the “van’t Hoff model” in binary {TP (1) + water (2)} combinations.
Table 4 summarizes the results for the correlation of CNZ in binary {TP (1) + water (2)} combinations with the “Yalkowsky–Roseman model”. The MPD for this model was estimated to be 24.76%, also showing a strong connection between experimental CNZ (3) solubility data and the “Yalkowsky–Roseman model” in binary {TP (1) + water (2)} combinations.
The solubility values of CNZ (3) in {TP (1) + water (2)} compositions at various temperatures and cosolvent compositions can also be correlated using the “Jouyban–Acree and Jouyban–Acree–van’t Hoff models” [28]. The overall MPDs were determined as 1.24% and 1.52% for “Jouyban–Acree and Jouyban–Acree–van’t Hoff models”, respectively. The overall MPD for the “Yalkowsky–Roseman model” was the highest compared with the other models studied. In the “Yalkowsky–Roseman model”, the model parameters were not utilized (equal to zero) compared to the other models studied. Therefore, the highest MPD value for the “Yalkowsky–Roseman model” was due to the fact that this model did not utilize any model parameters for the calculation of MPD [19,26].

2.4. Apparent Thermodynamic Parameters for CNZ

The apparent standard enthalpy (ΔsolnH°) values for CNZ (3) in all cosolvent mixtures, including neat solvents, were calculated using the van’t Hoff technique. As reported in Table 5, Figure 3 displays the linear van’t Hoff curves of CNZ (3) in all cosolvent compositions and pure solvents where R2 was more than 0.990. Table 5 also includes the values of all thermodynamic quantities. The CNZ (3) ΔsolnH° values in binary {TP (1) + water (2)} combinations with pure solvents ranged from 9.719 to 47.65 kJ mol−1. In various {TP (1) + water (2)} mixtures including neat solvents, the apparent standard Gibbs energy (ΔsolnG°) values for CNZ (3) were computed between 7.492 and 41.32 kJ mol−1. The endothermic dissolution of CNZ (3) in various {TP (1) + water (2)} combinations with pure solvents was demonstrated by the obtained values of ΔsolnH° for CNZ [18,19]. The ΔsolnH° and ΔsolnG° values are inversely proportional to the solubility of the solute. Hence, the maximum ΔsolnH° and ΔsolnG° values for CNZ were obtained in neat water compared to the neat TP. The apparent standard entropy (ΔsolnS°) values for CNZ (3) in binary {TP (1) + water (2)} combinations with neat solvents were computed between 7.346 and 23.94 J mol−1 K−1, implying the entropy-driven dissolution of CNZ (3) in diverse {TP (1) + water (2)} combinations with pure solvents [18]. Finally, in all {TP (1) + water (2)} combinations, including pure solvents, the dissolution of CNZ (3) was reported to be endothermic and entropy-driven [18,19].

2.5. Enthalpy–Entropy Compensation Analysis

An enthalpy–entropy compensation study was used to analyze the solvation behavior/cosolvent action of CNZ (3) in binary {TP (1) + water (2)} combinations with pure solvents, and the findings are shown in Figure 4. Figure 4 shows that CNZ (3) offers a linear ΔsolnH° vs. ΔsolnG° trend in all {TP (1) + water (2)} combinations with pure solvents, with a slope value of 1.124 and R2 = 0.997. Based on these findings, the driving mechanism for CNZ (3) solvation in all {TP (1) + water (2)} combinations, including neat solvents, is assumed to be enthalpy-driven. This method of CNZ solvation could be explained by the fact that CNZ solvates best in neat TP molecules compared to neat water molecules [19,28]. As a result, the molecular interactions between CNZ–TP molecules were stronger than those between CNZ–water molecules. This solvation behavior of CNZ (3) in binary {TP (1) + water (2)} combinations with pure solvents was identical to that of flufenamic acid, piperine, sinapic acid, sunitinib malate, apigenin, and apremilast in binary {TP (1) + water (2)} combinations [18,19,20,29,30,31].

3. Materials and Methods

3.1. Materials

CNZ (mass fraction purity > 0.99 by HPLC) was procured from FDC Ltd. (Mumbai, India). TP (mass fraction purity > 0.99 by GC) was obtained from Gattefosse (Lyon, France). The water utilized in this research was deionized and came from the laboratory’s Milli-Q unit. Table 6 summarizes the materials information.

3.2. CNZ (3) Solubility Determination in Binary {TP (1) + Water (2)} Combinations

Using a Digital Analytical Balance (Mettler Toledo, Greifensee, Switzerland) with a sensitivity of 0.10 mg, all {TP (1) + water (2)} combinations were created on a mass basis. The mass fraction of TP used to make various {TP (1) + water (2)} compositions ranged from 0.10–0.90. Three replicates of each {TP (1) + water (2)} composition were made.
Using a standard shake-flask method [32], the mole fraction solubility of CNZ against the mass fraction of TP (w1 = 0.0–1.0; w1 is TP mass fraction in {TP (1) + water (2)} compositions) and pure solvents was tested from 293.2–313.2 K and at 0.1 MPa in various {TP (1) + water (2)} mixtures and pure solvents. Extra CNZ crystals were mixed with known amounts of each {TP (1) + water (2)} composition and neat solvents. Three repetitions of each experiment were carried out. Inside the Biological Shaker (Julabo, PA, USA), the acquired samples were saturated for three days to achieve equilibrium. After reaching equilibrium, the saturated samples were withdrawn from the shaker and centrifuged at 5000 rpm. The supernatants were withdrawn, diluted (wherever applicable), and used for the estimation of CNZ content using a reported HPLC method at 253 nm [12]. The mole fraction solubilities (xe) of CNZ were calculated using their standard formulae [20,33].

3.3. HSPs of CNZ and Various {TP (1) + Water (2)} Mixtures

The HSP of a pharmaceutical compound is associated with its solubility in neat solvent or aqueous-cosolventmixtures. It is well-known that the closed value of the HSP of a pharmaceutical compound with that of a particular solvent could result in the maximum solubility of a pharmaceutical compound in that particular solvent [34]. Hence, the HSP for CNZ, neat TP, and neat water were predicted in this research. The δt value for CNZ, neat TP, and neat water was predicted using Equation (1) [35,36,37,38]:
δ t 2 = δ d 2 + δ p 2 + δ h 2
where δd = dispersion HSP; δp = polar HSP, and δh = hydrogen-bonded HSP. These values for CNZ and neat solvents were predicted utilizing HSPiP software (version 4.1.07, Louisville, KY, USA) by entering the simplified molecular input line entry system (SMILES) of each component into the HSPiP system [36].
The HSP for various {TP (1) + water (2)} mixture free of CNZ (δmix) was calculated using Equation (2) [38]:
δ mix = δ 1 + 1 δ 2
where, α = volume fraction of TP in {TP (1) + water (2)} mixture; δ1 = HSP of neat TP, and δ2 = HSP of neat water.

3.4. Cosolvency-Based Mathematical Models for CNZ Solubility Correlation

The mathematical correlation of experimental data of pharmaceutical compounds is important for practical predictions/validations [20,33,39,40]. As a result, the measured solubility values of CNZ were predicted using the modified “Apelblat, van’t Hoff, Yalkowsky–Roseman, Jouyban–Acree, and Jouyban–Acree–van’t Hoff models” [18,19,20,24,25,26,27].
The “Apelblat model solubility (xApl)” of CNZ (3) in binary {TP (1) + water (2)} combinations was predicted using Equation (3) [24,25]:
ln   x Apl = A + B T + C ln T
where A, B, and C are the model parameters of Equation (3), which were determined using nonlinear multivariate regression analysis of experimental solubility data of CNZ summarized in Table 1 [18]. The correlation between xe and xApl of CNZ was performed using MPD. The MPD was calculated using its reported formula [27].
The “van’t Hoff model solubility (xvan’t)” of CNZ (3) in binary {TP (1) + water (2)} combinations is predicted using Equation (4) [20]:
ln x van t = a + b T
where a and b are the Equation (4) parameters, which were found using the least square technique [19]. The solubility values in a specific solvent combination at different temperatures are represented by Equations (3) and (4), and there is no way to forecast the solubility values in other solvent mixtures of binary solvent composition.
The logarithmic solubility of the “Yalkowsky–Roseman model (log xYal)” for CNZ (3) in various {TP (1) + water (2)} combinations was predicted by Equation (5) [26]:
log x Yal = w 1 log x 1 + w 2 log x 2
where x1 = the solubility of CNZ (3) in TP (1); x2 = the solubility of CNZ in water (2); w1 = TP mass fraction, and w2 = water mass fraction. Equation (5) models the solubility values of pharmaceutical compounds in different solvent mixtures at a given temperature.
The “Jouyban–Acree model” correlates the solubility of pharmaceutical compounds at the solvent compositions as well as temperature (xm,T), and was predicted using Equation (6) [27]:
ln x m , T = w 1 ln x 1 , T + w 2 ln x 2 , T + w 1 . w 2 T i = 0 2 J i w 1 w 2 i
where x1,T and x2,T are the solubility of CNZ in TP (1) and water (2) at temperature T, and the symbols J are the model parameters. The solubility values of CNZ in pure solvents are required as input data to predict the solubility of CNZ in cosolvent compositions at the temperature of interest. To overcome this constraint, Equations (2) and (6) can be combined to form the “Jouyban–Acree–van’t Hoff model” [27].

3.5. Apparent Thermodynamic Parameters for CNZ

At the mean harmonic temperature (Thm), all apparent thermodynamic parameters were examined. The Thm was calculated using the usual formula [27]. In this study, the Thm was found to be 303.0 K. An apparent thermodynamic analysis was used to calculate several apparent thermodynamic parameters. The van’t Hoff and Gibbs equations were used to conduct this analysis. Equation (7) was used to determine the ΔsolnH° values for CNZ (3) in binary {TP (1) + water (2)} combinations at Thm = 303.0 K using the van’t Hoff methodology [28,41]:
ln x e 1 T 1 T hm P = Δ soln H ° R
By plotting ln xe values of CNZ vs. (1/T−1/Thm), the ΔsolnH° and ΔsolnG° values for CNZ were calculated from the slope and intercept, using the following Equations (8) and (9), respectively [28,41]:
Δ soln H ° = R ln x e 1 T 1 T hm P
Δ soln G ° = R T hm · intercept
Equation (10) was used to calculate the ΔsolnS° values for CNZ (3) in binary {TP (1) + water (2)} combinations [28,41,42]:
Δ soln S ° = Δ soln H ° Δ soln G ° T hm

3.6. Enthalpy–Entropy Compensation Analysis

An enthalpy–entropy compensation analysis was used to analyze the solvation behavior of CNZ (3) in binary {TP (1) + water (2)} combinations, as previously proposed [16]. This analysis was carried out by plotting the weighted graphs of ΔsolnH° vs. ΔsolnG° at Thm = 303.0 K [17,26].

4. Conclusions

In the literature, there is scarce data concerning the solubility of CNZ in diverse aqueous cosolvent mixtures. As a result, the mole fraction solubility data of a weak base, CNZ, (3) in binary {TP (1) + water (2)} combinations including pure solvents was determined in this investigation from 293.2–313.2 K and at 0.1 MPa. In all {TP (1) + water (2)} compositions, including pure solvents, the mole fraction solubilities of CNZ (3) increased with the rise in temperature and TP mass fraction. At each temperature tested, the maximum and minimum mole fraction solubility of CNZ were found in neat TP and neat water, respectively. In all {TP (1) + water (2) combinations including pure solvents, experimentally determined CNZ (3) solubility data correlated well with the “Apelblat, van’t Hoff, Yalkowsky–Roseman, Jouyban–Acree, and Jouyban–Acree–van’t Hoff models”. In all {TP (1) + water (2)} combinations, including pure solvents, the dissolution behavior of CNZ was endothermic and entropy-driven. In all {TP (1) + water (2)} combinations, including pure solvents, the predominant mechanism for CNZ solvation capacity was enthalpy-driven.

Author Contributions

Conceptualization, F.S. and M.K.; methodology, P.A. and F.K.A.; software, P.A.; validation, M.K. and F.K.A.; formal analysis, M.K.; investigation, F.S.; resources, M.K.; data curation, P.A.; writing—original draft preparation, F.S.; writing—review and editing, M.K.; visualization, M.K.; supervision, F.S.; project administration, F.S.; funding acquisition, M.K. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the National Plan for Science, Technology, and Innovation (MAARIFAH), King Abdulaziz City for Science and Technology, Saudi Arabia, Award Number (13NAN929-02) and the APC was funded by MAARIFAH.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

This study did not report any data.

Acknowledgments

Authors are thankful to the National Plan for Science, Technology, and Innovation (MAARIFAH), King Abdulaziz City for Science and Technology, Saudi Arabia, Award Number (13NAN929-02) for supporting this work.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Samples of the compounds CNZ are available from the authors.

References

  1. Paus, R.; Hart, E.; Ji, Y.; Sadowski, G. Solubility and caloric properties of cinnarizine. J. Chem. Eng. Data 2015, 60, 2256–2261. [Google Scholar] [CrossRef]
  2. Raghuvanshi, S.; Pathak, K. Recent advances in drug delivery systems and therapeutics of cinnarizine: A poorly water soluble drug with absorption window in stomach. J. Drug Deliv. 2014, 2014, 479246. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Shi, S.; Chen, H.; Lin, X.; Tang, X. Pharmacokinetics, tissue distribution and safety of cinnarizine delivered in lipid emulsion. Int. J. Pharm. 2010, 383, 264–270. [Google Scholar] [CrossRef]
  4. Amidon, G.L.; Lennernas, H.; Shah, V.P.; Crison, J.R. A theoretical basis for a biopharmaceutic drug classification-the correlation of in-vitro drug product dissolution and in-vivo bioavailability. Pharm. Res. 1995, 12, 413–420. [Google Scholar] [CrossRef] [Green Version]
  5. Loftsson, T.; Hreinsdóttir, D.; Másson, M. Evaluation of cyclodextrin solubilization of drugs. Int. J. Pharm. 2005, 302, 18–28. [Google Scholar] [CrossRef] [PubMed]
  6. Sassene, P.J.; Knopp, M.M.; Hesselkilde, J.Z.; Koradia, V.; Larsen, A.; Rades, T.; Mullertz, A. Precipitation of a poorly soluble model drug during in vitro lipolysis: Characterization and dissolution of the precipitate. J. Pharm. Sci. 2010, 99, 4982–4991. [Google Scholar] [CrossRef] [PubMed]
  7. Larsen, A.T.; Ogbonna, A.; Abu-Rmaileh, R.; Abrahamsson, B.; Østergaard, J.; Mullertz, A. SNEDDS containing poorly water soluble cinnarizine; development and in vitro characterization of dispersion, digestion and solubilization. Pharmaceutics 2012, 4, 641–655. [Google Scholar] [CrossRef] [Green Version]
  8. Shahba, A.A.-W.; Mohsin, K.; Alanazi, F.K. Novel self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery cinnarizine: Design, optimization, and in-vitro assessment. AAPS PharmSciTech. 2012, 13, 967–977. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  9. Rai, S.; Yasir, M. Cinnarizine-loaded lipid based system: Preparation, optimization, and in-vitro evaluation. IOSR J. Pharm. 2012, 2, 47–56. [Google Scholar] [CrossRef]
  10. Larsen, A.T.; Ohlsson, A.G.; Polentarutti, B.; Barker, R.A.; Phillips, A.R.; Abu-Rmaileh, R.; Dickinson, P.A.; Abrahamsson, B.; Østergaard, J.; Mullertz, A. Oral bioavailability of cinnarizine in dogs: Relation to SNEDDS droplet size, drug solubility and in vitro precipitation. Eur. J. Pharm. Sci. 2013, 48, 339–350. [Google Scholar] [CrossRef]
  11. Shahba, A.A.-W.; Mohsin, K.; Alanazi, F.K.; Abdel-Rahman, S.I. Optimization of self-nanoemulsifying formulations for weakly basic lipophilic drugs: Role of acidification and experimental design. Br. J. Pharm. Sci. 2016, 52, 654–667. [Google Scholar] [CrossRef] [Green Version]
  12. Jørgensen, S.D.S.; Rades, T.; Mu, H.; Graeser, K.; Mullertz, A. Exploring the utility of the chasing principle: Influence of drug-free SNEDDS composition on solubilization of carvedilol, cinnarizine and R3040 in aqueous suspension. Acta Pharm. Sin. B. 2019, 9, 194–201. [Google Scholar] [CrossRef]
  13. Ilie, A.-R.; Griffin, B.T.; Vertzoni, M.; Kuentz, M.; Kolakovic, R.; Prudic-Paus, A.; Malash, A.; Bohets, H.; Herman, J.; Holm, R. Exploring precipitation inhibitors to improve in vivo absorption of cinnarizine from supersaturated lipid-based drug delivery systems. Eur. J. Pharm. Sci. 2021, 159, 105691. [Google Scholar] [CrossRef] [PubMed]
  14. Shahba, A.A.; Tashish, A.Y.; Alanazi, F.K.; Kazi, M. Combined self-nanoemulsifying and solid dispersion systems showed enhanced cinnarizine release in hypochlorhydria/achlorhydria dissolution model. Pharmaceutics 2021, 13, 627. [Google Scholar] [CrossRef] [PubMed]
  15. Ruether, F.; Sadowski, G. Modeling the solubility of pharmaceuticals in pure solvents and solvent mixtures for drug process design. J. Pharm. Sci. 2009, 98, 4205–4215. [Google Scholar] [CrossRef]
  16. Blagden, N.; De Matas, M.; Gavan, P.; York, P. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates. Adv. Drug Deliv. Rev. 2007, 59, 617–630. [Google Scholar] [CrossRef]
  17. Kazi, M.; Alhajri, A.; Alshehri, S.M.; Elzayat, E.M.; Al Meanazel, O.T.; Shakeel, F.; Noman, O.; Altamimi, M.A.; Alanazi, F.K. Enhancing oral bioavailability of apigenin using a bioactive self-nanoemulsifying drug delivery system (Bio-SNEDDS): In vitro, in vivo and stability evaluations. Pharmaceutics 2020, 12, 749. [Google Scholar] [CrossRef] [PubMed]
  18. Alshehri, S.; Shakeel, F. Solubility determination, various solubility parameters and solution thermodynamics of sunitinib malate in some cosolvents, water and various (Transcutol + water) mixtures. J. Mol. Liq. 2020, 307, 112970. [Google Scholar] [CrossRef]
  19. Shakeel, F.; Alshehri, S. Solubilization, Hansen solubility parameters, solution thermodynamics and solvation behavior of flufenamic acid in (Carbitol + water) mixtures. Processes 2020, 8, 1204. [Google Scholar] [CrossRef]
  20. Shakeel, F.; Haq, N.; Alanazi, F.K.; Alanazi, S.A.; Alsarra, I.A. Solubility of sinapic acid in various (Carbitol + water) systems: Computational modeling and solution thermodynamics. J. Thermal Anal. Calorim. 2020, 142, 1437–1446. [Google Scholar] [CrossRef]
  21. Jouyban, A.; Acree, W.E., Jr.; Martinez, F. Preferential solvation of apremilast in some (Transcutol® + water) mixtures. J. Mol. Liq. 2020, 316, 113905. [Google Scholar] [CrossRef]
  22. Barzegar-Jalali, M.; Agha, E.M.H.; Adibkia, K.; Martinez, F.; Jouyban, A. The solubility of ketoconazole in binary carbitol + water mixtures at T = (293.2313.2) K. J. Mol. Liq. 2020, 297, 111756. [Google Scholar] [CrossRef]
  23. Osoria, I.P.; Martinez, F.; Pena, M.A.; Jouyban, A.; Acree, W.E., Jr. Solubility of sulphadiazine in some {Carbitol® (1) + water (2)} mixtures: Determination, correlation, and preferential solvation. Phys. Chem. Liq. 2021, 59, 890–906. [Google Scholar] [CrossRef]
  24. Apelblat, A.; Manzurola, E. Solubilities of o-acetylsalicylic, 4-aminosalicylic, 3,5-dinitrosalicylic and p-toluic acid and magnesium-DL-aspartate in water from T = (278–348) K. J. Chem. Thermodyn. 1999, 31, 85–91. [Google Scholar] [CrossRef]
  25. Manzurola, E.; Apelblat, A. Solubilities of L-glutamic acid, 3-nitrobenzoic acid, acetylsalicylic, p-toluic acid, calcium-L-lactate, calcium gluconate, magnesium-DL-aspartate, and magnesium-L-lactate in water. J. Chem. Thermodyn. 2002, 34, 1127–1136. [Google Scholar] [CrossRef]
  26. Yalkowsky, S.H.; Roseman, T.J. Solubilization of drugs by cosolvents. In Techniques of Solubilization of Drugs; Yalkowsky, S.H., Ed.; Marcel Dekker Inc.: New York, NY, USA, 1981; pp. 91–134. [Google Scholar]
  27. Akay, S.; Kayan, B.; Jouyban, A.; Martinez, F.; Acree, W.E., Jr. Equilibrium solubility vanillin in some (ethanol + water) mixtures: Determination, correlation, thermodynamics and preferential solvation. J. Mol. Liq. 2021, 342, 117529. [Google Scholar] [CrossRef]
  28. Ruidiaz, M.A.; Delgado, D.R.; Martínez, F.; Marcus, Y. Solubility and preferential solvation of indomethacin in 1,4-dioxane + water solvent mixtures. Fluid Phase Equilib. 2010, 299, 259–265. [Google Scholar] [CrossRef]
  29. Shakeel, F.; Haq, N.; Alshehri, S. Solubility data of the bioactive compound piperine in (Transcutol + water) mixtures: Computational modeling, Hansen solubility parameters and mixing thermodynamic properties. Molecules 2020, 25, 2743. [Google Scholar] [CrossRef]
  30. Shakeel, F.; Alshehri, S.; Haq, N.; Elzayat, E.; Ibrahim, M.; Altamimi, M.A.; Mohsin, K.; Alanazi, F.K.; Alsarra, I.A. Solubility determination and thermodynamic data of apigenin in binary {Transcutol® + water} mixtures. Ind. Crops Prod. 2018, 116, 56–63. [Google Scholar] [CrossRef]
  31. Shakeel, F.; Haq, N.; Alanazi, F.K.; Alsarra, I.A. Solubility and thermodynamic function of apremilast in different (Transcutol + water) cosolvent mixtures: Measurement, correlation and molecular interactions. J. Ind. Eng. Chem. 2017, 56, 99–107. [Google Scholar] [CrossRef]
  32. Higuchi, T.; Connors, K.A. Phase-solubility techniques. Adv. Anal. Chem. Inst. 1965, 4, 117–122. [Google Scholar]
  33. Shakeel, F.; Haq, N.; Salem-Bekhit, M.M.; Raish, M. Solubility and dissolution thermodynamics of sinapic acid in (DMSO + water) binary solvent mixtures at different temperatures. J. Mol. Liq. 2017, 225, 833–839. [Google Scholar] [CrossRef]
  34. Zhu, Q.N.; Wang, Q.; Hu, Y.B.; Abliz, X. Practical determination of the solubility parameters of 1-alkyl-3-methylimidazolium bromide ([CnC1im]Br, n = 5, 6, 7, 8) ionic liquids by inverse gas chromatography and the Hansen solubility parameter. Molecules 2019, 24, 1346. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Alanazi, A.; Alshehri, S.; Altamimi, M.; Shakeel, F. Solubility determination and three dimensional Hansen solubility parameters of gefitinib in different organic solvents: Experimental and computational approaches. J. Mol. Liq. 2020, 299, 112211. [Google Scholar] [CrossRef]
  36. Kalam, M.A.; Alshamsan, A.; Alkholief, M.; Alsarra, I.A.; Ali, R.; Haq, N.; Anwer, M.K.; Shakeel, F. Solubility measurement and various solubility parameters of glipizide in different neat solvents. ACS Omega 2020, 5, 1708–1716. [Google Scholar] [CrossRef] [PubMed]
  37. Anwer, M.K.; Muqtader, M.; Iqbal, M.; Ali, R.; Almutairy, B.K.; Alshetaili, A.; Alshahrani, S.M.; Aldawsari, M.F.; Alalaiwe, A.; Shakeel, F. Estimating the solubility, solution thermodynamics, and molecular interactions of aliskiren hemifumarate in alkyl imidazolium based ionic liquids. Molecules 2019, 24, 2807. [Google Scholar] [CrossRef] [Green Version]
  38. Wan, Y.; He, H.; Huang, Z.; Zhang, P.; Sha, J.; Li, T.; Ren, B. Solubility, thermodynamic modeling and Hansen solubility parameter of 5-norbornene-2,3-dicarboximide in three binary solvents (methanol, ethanol, ethyl acetate + DMF) from 278.15 K to 323.15 K. J. Mol. Liq. 2020, 300, E112097. [Google Scholar] [CrossRef]
  39. Mondal, P.; Roy, S.; Loganathan, G.; Mandal, B.; Dharumadurai, D.; Akbarsha, M.A.; Sengupta, P.S.; Chattopadhyay, S.; Guin, P.S. 1-Amino-4-hydroxy-9,10-anthraquinone—An analogue of anthracycline anticancer drugs, interacts with DNA and induces apoptosis in human MDA-MB-231 breast adinocarcinoma cells: Evaluation of structure–activity relationship using computational, spectroscopic and biochemical studies. Biochem. Biophys. Rep. 2015, 4, 321–323. [Google Scholar]
  40. Banerjee, S.; Roy, S.; Datta, A.; Mondal, P.; Mishra, M.; Perumalsamy, B.; Thirmurugan, R.; Dharumadurai, D.; Das, S.; Guin, P.S. Solubilization of sodium 3-amino-2-hydroxyanthraquinone-1-sulfonate in sodium dodecyl sulfate micelles explains its permeation in A549 human lung cancer cell. J. Chin. Chem. Soc. 2021, 68, 250–262. [Google Scholar] [CrossRef]
  41. Krug, R.R.; Hunter, W.G.; Grieger, R.S. Enthalpy-entropy compensation. 2. Separation of the chemical from the statistic effect. J. Phys. Chem. 1976, 80, 2341–2351. [Google Scholar] [CrossRef]
  42. Holguín, A.R.; Rodríguez, G.A.; Cristancho, D.M.; Delgado, D.R.; Martínez, F. Solution thermodynamics of indomethacin in propylene glycol + water mixtures. Fluid Phase Equilib. 2012, 314, 134–139. [Google Scholar] [CrossRef]
Figure 1. Molecular structure of cinnarizine (CNZ).
Figure 1. Molecular structure of cinnarizine (CNZ).
Molecules 26 07052 g001
Figure 2. Influence of Transcutol-P (TP) mass fraction (w1) on logarithmic solubilities of CNZ between 293.2 and 313.2 K.
Figure 2. Influence of Transcutol-P (TP) mass fraction (w1) on logarithmic solubilities of CNZ between 293.2 and 313.2 K.
Molecules 26 07052 g002
Figure 3. Van’t Hoff curves for logarithmic solubility of CNZ (3) in aqueous mixtures of TP (1) and water (2).
Figure 3. Van’t Hoff curves for logarithmic solubility of CNZ (3) in aqueous mixtures of TP (1) and water (2).
Molecules 26 07052 g003
Figure 4. ΔsolH° vs. ΔsolG° enthalpy–entropy compensation plot for solubility of CNZ in various {TP (1) + water (2)} mixtures at Thm = 303.0 K.
Figure 4. ΔsolH° vs. ΔsolG° enthalpy–entropy compensation plot for solubility of CNZ in various {TP (1) + water (2)} mixtures at Thm = 303.0 K.
Molecules 26 07052 g004
Table 1. Solubility values (xe) of cinnarizine (CNZ) in mole fraction (3) in binary {Transcutol-P (TP) (1) + water (2)} combinations from 293.2–313.2 K and at 0.1 MPa a.
Table 1. Solubility values (xe) of cinnarizine (CNZ) in mole fraction (3) in binary {Transcutol-P (TP) (1) + water (2)} combinations from 293.2–313.2 K and at 0.1 MPa a.
w1axeb
T = 293.2 KT = 298.2 KT = 303.2 KT = 308.2 KT = 313.2 K
0.03.91 × 10−85.67 × 10−87.82 × 10−89.78 × 10−81.42 × 10−7
0.11.66 × 10−72.30 × 10−73.16 × 10−73.91 × 10−75.30 × 10−7
0.26.50 × 10−78.87 × 10−71.23 × 10−61.51 × 10−61.95 × 10−6
0.32.64 × 10−63.50 × 10−64.49 × 10−65.35 × 10−67.00 × 10−6
0.41.12 × 10−51.42 × 10−51.72 × 10−52.09 × 10−52.62 × 10−5
0.54.24 × 10−55.26 × 10−56.34 × 10−57.33 × 10−59.22 × 10−5
0.61.73 × 10−42.10 × 10−42.44 × 10−42.77 × 10−43.36 × 10−4
0.76.89 × 10−48.00 × 10−49.22 × 10−41.05 × 10−31.23 × 10−3
0.82.81 × 10−33.17 × 10−33.53 × 10−33.90 × 10−34.43 × 10−3
0.91.12 × 10−21.25 × 10−21.38 × 10−21.48 × 10−21.62 × 10−2
1.04.52 × 10−24.78 × 10−25.08 × 10−25.44 × 10−25.83 × 10−2
a The uncertainties u are u(T) = 0.2 K, u(w1) = 0.0007, and u(p) = 2 kPa. b The relative uncertainty ur in solubility is ur(xe) = 0.016.
Table 2. Results for the modified “Apelblat model” for CNZ (3) in various {TP (1) + water (2)} combinations.
Table 2. Results for the modified “Apelblat model” for CNZ (3) in various {TP (1) + water (2)} combinations.
w1ABCR2MPD (%)
0.0224.09−15741−32.9970.9956-
0.1286.07−18057−42.2640.9979-
0.2442.94−24887−65.5360.9980-
0.3211.39−13815−31.1760.9969-
0.4−25.275−2611.04.01120.9988-
0.58.3136−3761.7−0.976480.99572.27
0.653.365−5294.9−7.73890.9956-
0.7−72.315715.4311.0180.9955-
0.8−46.705101.837.12630.9981-
0.9127.04−7373.2−18.7280.9994-
1.0−132.564855.219.8750.9998-
Table 3. Resulting data for “van’t Hoff model” for CNZ (3) in different {TP (1) + water (2)} combinations.
Table 3. Resulting data for “van’t Hoff model” for CNZ (3) in different {TP (1) + water (2)} combinations.
w1abR2MPD (%)
0.02.5154−5733.00.9947
0.12.2793−5240.50.9967
0.22.8838−5015.90.9953
0.32.0440−4360.60.9959
0.41.6487−3824.20.9987
0.51.7473−3462.80.99545.15
0.61.3939−2946.30.9952
0.71.6646−2623.10.9993
0.81.1397−2057.00.9978
0.91.2918−1694.40.9973
1.00.88450−1169.30.9960
Table 4. Resulting data for “Yalkowsky–Roseman model” for CNZ (3) in different {TP (1) + water (2)} combinations from 293.2–313.2 K.
Table 4. Resulting data for “Yalkowsky–Roseman model” for CNZ (3) in different {TP (1) + water (2)} combinations from 293.2–313.2 K.
w1log xYalMPD (%)
T = 293.2 KT = 298.2 KT = 303.2 KT = 308.2 KT = 313.2 K-
0.1−6.80−6.65−6.52−6.43−6.28-
0.2−6.19−6.06−5.94−5.86−5.72-
0.3−5.58−5.46−5.36−5.28−5.16-
0.4−4.98−4.87−4.78−4.71−4.6024.76
0.5−4.37−4.28−4.20−4.13−4.04-
0.6−3.77−3.69−3.61−3.56−3.47-
0.7−3.16−3.09−3.03−2.98−2.91-
0.8−2.55−2.50−2.45−2.41−2.35-
0.9−1.95−1.91−1.87−1.83−1.79-
Table 5. Apparent standard enthalpy (ΔsolnH°), apparent standard Gibbs energy (ΔsolnG°), apparent standard entropy (ΔsolnS°), and van’t Hoff R2 values for CNZ (3) in different {TP (1) + water (2)} combinations at Thm = 303.0 K a.
Table 5. Apparent standard enthalpy (ΔsolnH°), apparent standard Gibbs energy (ΔsolnG°), apparent standard entropy (ΔsolnS°), and van’t Hoff R2 values for CNZ (3) in different {TP (1) + water (2)} combinations at Thm = 303.0 K a.
w1ΔsolnH°/kJ mol−1ΔsolnG°/kJ mol−1ΔsolnS°/J mol−1 K−1R2
0.047.6541.3220.480.994
0.143.5637.8218.920.996
0.241.6934.4323.940.995
0.336.2431.1016.960.995
0.431.7827.6413.680.998
0.528.7824.3814.500.995
0.624.4920.9811.570.995
0.721.8017.6113.820.999
0.817.0914.239.4640.997
0.914.0810.8310.720.997
1.09.7197.4927.3460.996
a The relative uncertainties are ursolnH0) = 0.043, ursolnG0) = 0.045, and ursolnS0) = 0.034.
Table 6. Materials list.
Table 6. Materials list.
MaterialMolecular FormulaMolar Mass (g mol−1)CAS RNPurification MethodMass Fraction PurityAnalysis MethodSource
CNZC26H28N2368.50298-57-7None>0.99HPLCFDC Ltd.
TPC6H14O3134.17111-90-0None>0.99GCGattefosse
WaterH2O18.077732-18-5None--Milli-Q
CNZ: cinnarizine; TP: Transcutol-P; HPLC: high-performance liquid chromatography; GC: gas chromatography.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Shakeel, F.; Kazi, M.; Alanazi, F.K.; Alam, P. Solubility of Cinnarizine in (Transcutol + Water) Mixtures: Determination, Hansen Solubility Parameters, Correlation, and Thermodynamics. Molecules 2021, 26, 7052. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules26227052

AMA Style

Shakeel F, Kazi M, Alanazi FK, Alam P. Solubility of Cinnarizine in (Transcutol + Water) Mixtures: Determination, Hansen Solubility Parameters, Correlation, and Thermodynamics. Molecules. 2021; 26(22):7052. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules26227052

Chicago/Turabian Style

Shakeel, Faiyaz, Mohsin Kazi, Fars K. Alanazi, and Prawez Alam. 2021. "Solubility of Cinnarizine in (Transcutol + Water) Mixtures: Determination, Hansen Solubility Parameters, Correlation, and Thermodynamics" Molecules 26, no. 22: 7052. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules26227052

Article Metrics

Back to TopTop